1,373 results on '"Schumacher, Ton"'
Search Results
2. Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma
3. Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
4. Gene and protein sequence features augment HLA class I ligand predictions
5. DRAG in situ barcoding reveals an increased number of HSPCs contributing to myelopoiesis with age
6. Identification of patient-specific CD4+ and CD8+ T cell neoantigens through HLA-unbiased genetic screens
7. The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer
8. Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
9. Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response
10. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial
11. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
12. B cells and tertiary lymphoid structures promote immunotherapy response
13. An adverse tumor-protective effect of IDO1 inhibition
14. Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer
15. Non-clinical evaluation of NT-112, an autologous T cell product engineered to express an HLA-C*08:02-restricted TCR targeting KRAS G12D and resistant to TGF-b inhibition.
16. The precursors of CD8+ tissue resident memory T cells: from lymphoid organs to infected tissues
17. Replicative history marks transcriptional and functional disparity in the CD8+ T cell memory pool
18. T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
19. The Human Cell Atlas.
20. Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening
21. CD8-targeted IL2 unleashes tumor-specific immunity in human cancer tissue by reviving the dysfunctional T cell pool
22. IL-2 targeted to CD8+ T cells promotes robust effector T cell responses and potent antitumor immunity
23. CD29 identifies IFN-γ–producing human CD8⁺ T cells with an increased cytotoxic potential
24. Single-cell analysis of regions of interest (SCARI) using a photosensitive tag
25. An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer
26. DNA damage induces p53-independent apoptosis through ribosome stalling
27. Distinct spatiotemporal dynamics of CD8+ T cell-derived cytokines in the tumor microenvironment
28. Labeling and tracking of immune cells in ex vivo human skin
29. Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
30. The “cancer immunogram”
31. CANCER IMMUNOLOGY. The "cancer immunogram".
32. Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial
33. Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features
34. Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma
35. CD8+ T cell states in human cancer: insights from single-cell analysis
36. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
37. Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted IFN-γ
38. Tumor organoid–T-cell coculture systems
39. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
40. Author Correction: Replicative history marks transcriptional and functional disparity in the CD8+ T cell memory pool
41. DNA damage induces p53-independent apoptosis through ribosome stalling.
42. 1006 High doses of MHC-II neoantigens in peptide cancer vaccines induce tumor-specific inhibitory cytolytic CD4+T cells
43. CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1
44. Gene and protein sequence features augment HLA class I ligand predictions
45. Defining ‘T cell exhaustion’
46. Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
47. Induction of neoantigen-reactive T cells from healthy donors
48. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
49. Tissue patrol by resident memory CD8+ T cells in human skin
50. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.